Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes

P Lunetti, M Di Giacomo, D Vergara… - The FEBS …, 2019 - Wiley Online Library
Mitochondrial dysfunction is a key feature of cancer and is frequently associated with
increased aggressiveness and metastatic potential. Recent evidence has brought to light a …

Mitochondrial flexibility of breast cancers: a growth advantage and a therapeutic opportunity

A Avagliano, MR Ruocco, F Aliotta, I Belviso, A Accurso… - Cells, 2019 - mdpi.com
Breast cancers are very heterogeneous tissues with several cell types and metabolic
pathways together sustaining the initiation and progression of disease and contributing to …

Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function

U Martinez-Outschoorn, F Sotgia, MP Lisanti - Seminars in oncology, 2014 - Elsevier
Metabolic synergy or metabolic coupling between glycolytic stromal cells (Warburg effect)
and oxidative cancer cells occurs in human breast cancers and promotes tumor growth. The …

Mitochondrial dysfunction: a novel potential driver of epithelial-to-mesenchymal transition in cancer

F Guerra, N Guaragnella, AA Arbini, C Bucci… - Frontiers in …, 2017 - frontiersin.org
Epithelial-to-mesenchymal transition (EMT) allows epithelial cancer cells to assume
mesenchymal features, endowing them with enhanced motility and invasiveness, thus …

Mitochondrial metabolism: Yin and Yang for tumor progression

L Valcarcel-Jimenez, E Gaude, V Torrano… - Trends in Endocrinology …, 2017 - cell.com
Altered metabolism is a distinct feature of cancer cells. During transformation, the entire
metabolic network is rewired to efficiently convert nutrients to biosynthetic precursors to …

Elucidating the metabolic plasticity of cancer: mitochondrial reprogramming and hybrid metabolic states

D Jia, JH Park, KH Jung, H Levine, BA Kaipparettu - Cells, 2018 - mdpi.com
Aerobic glycolysis, also referred to as the Warburg effect, has been regarded as the
dominant metabolic phenotype in cancer cells for a long time. More recently, it has been …

Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia

K Smolková, N Bellance, F Scandurra, E Génot… - Journal of bioenergetics …, 2010 - Springer
Breast cancer cells can survive and proliferate under harsh conditions of nutrient
deprivation, including limited oxygen and glucose availability. We hypothesized that such …

[HTML][HTML] Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition

R Lamb, H Harrison, J Hulit, DL Smith, MP Lisanti… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Here, we used quantitative proteomics analysis to identify novel therapeutic targets in
cancer stem cells and/or progenitor cells. For this purpose, mammospheres from two ER …

Mitochondrial retrograde signalling and metabolic alterations in the tumour microenvironment

D Yang, J Kim - Cells, 2019 - mdpi.com
This review explores the molecular mechanisms that may be responsible for mitochondrial
retrograde signalling related metabolic reprogramming in cancer and host cells in the …

Lipid metabolism heterogeneity and crosstalk with mitochondria functions drive breast cancer progression and drug resistance

A Azam, NE Sounni - Cancers, 2022 - mdpi.com
Simple Summary Metabolic heterogeneity and mitochondrial function are important
parameters that might influence therapeutic vulnerabilities and predict the clinical outcomes …